Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Five Star Equities Issues New Research Reports on ACFN, ATOS, MACK and NSYS

ACFN, NSYS, ATOS

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.

Acorn Energy Inc. (NASDAQ: ACFN) shares spiked 9.14 percent to close at $3.70 a share Monday. The stock traded between $3.63 and $4.24 on volume of 1.09 million shares traded. Maxim Group analysts have recently upgraded their rating on the company to "buy" from "hold". Shares of Acorn Energy have fallen approximately 52.0 percent year-to-date.

Get more information on Acorn Energy and free access to the in-depth equity report at:
www.FiveStarEquities.com/ACFN

Atossa Genetics Inc. (NASDAQ: ATOS) shares soared 27.83 percent to close at $2.71 a share Monday. The stock traded between $2.10 and $2.73 on volume 1.27 million shares traded. The company announced that it attended a pre-510(k) submission meeting with the Food and Drug Administration on November 14th. Shares of Atossa Genetics have fallen approximately 30.0 percent year-to-date.

Get more information on Atossa Genetics and free access to the in-depth equity report at:
www.FiveStarEquities.com/ATOS

Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) shares gained 8.40 percent to close at $2.71 a share Monday. The stock traded between $2.50 and $2.71 on volume of 1.74 million shares traded. The company recently announced that it plans to report top line data for NAPOLI-1 in the second quarter of 2014. Shares of Merrimack Pharmaceuticals have fallen approximately 55.0 percent year-to-date.

Get more information on Merrimack Pharmaceuticals and free access to the in-depth equity report at:
www.FiveStarEquities.com/MACK

Nortech Systems Inc. (NASDAQ: NSYS) shares surged 16.67 percent to close at $7.00 a share Monday. The stock traded between $6.50 and $9.80 on volume 2.22 million shares traded. The company recently reported net sales were $27.4 million for the third quarter of 2013, an increase of 7.0 percent when compared to a year ago. Shares of Nortech Systems have gained approximately 130.0 percent year-to-date.

Get more information on Nortech Systems free access to the in-depth equity report at:
www.FiveStarEquities.com/NSYS

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today